EDMedix publishes U.S.-focused educational material on erectile dysfunction, prescription ED medications, safety and pharmacy access. This policy explains how we distinguish reliable clinical and regulatory evidence from advertising, how we define product-specific claims and how we handle corrections and commercial relationships.
Last updated: October 15, 2026
Our editorial standards apply to EDMedix pages about erectile dysfunction, sildenafil, tadalafil, vardenafil, avanafil, alprostadil, drug brands, generic products, dosing frameworks, side effects and commercial access. Content is intended to explain source-supported facts, not to replace a healthcare professional.
Each article should satisfy a defined user question. Ingredient hubs, brand pages, dose-strength catalogs, safety information, product comparisons and pharmacy guides may refer to one another but should not repeat the same material without a distinct purpose.
We prioritize factual accuracy, evidence proportional to the claim, useful distinctions between medicines and transparent limitations. We do not convert an encouraging study result into a guaranteed treatment outcome or a manufacturer’s promotional phrase into FDA labeling.
A clearly stated uncertainty can be more useful than a false claim of precision. Our goal is to show what information has been established and what a reader must still confirm with a clinician, regulator or pharmacist.
| Principle | How it applies |
|---|---|
| Product specificity | Identify active ingredient, strength, dosage form, label and indication |
| Evidence relevance | Use FDA records or suitable clinical research for the actual claim |
| Uncertainty | Distinguish approval, marketing status, NDC listing and stock |
| Independence | Separate safety conclusions from commissions and referrals |
| Accountability | Provide a route for correction requests and documented revisions |
For U.S. approved uses, dosing language, contraindications and product warnings, we prioritize product-specific FDA prescribing information and DailyMed. FDA Orange Book and Drugs@FDA records inform approvals, discontinued listings and applicable therapeutic-equivalence information.
For disease evaluation or study interpretation, we also consider specialty-society guidelines, systematic reviews and peer-reviewed trials. Foreign manufacturer catalogs may be appropriate to establish that a particular product is advertised in another market, but they are not substitutes for U.S. regulatory evidence.
| Question | Preferred source | Important limitation |
|---|---|---|
| U.S. indications and warnings | Product-specific FDA label or DailyMed | Check exact formulation and revision |
| Generic approval or equivalence | FDA Orange Book and Drugs@FDA | Apply to the named approved product |
| Foreign brand identity | Original company/label and corroborating records | Not proof of U.S. approval or lot authenticity |
| Trial efficacy or onset | Methods and results of appropriate clinical research | Endpoint and population must be stated |
| Pharmacy licensure | State board of pharmacy | Website appearance is not verification |
| Current prices and stock | Actual pharmacy, insurer or service provider | Cannot be inferred from evergreen articles |
Sildenafil, tadalafil, vardenafil and avanafil are oral PDE5 inhibitors used for ED under their respective U.S. labels. They share important class considerations but differ in dosing patterns, pharmacokinetics, product forms and interactions. Injectable alprostadil has a separate mechanism, device handling and clinician training requirements.
We avoid implying a lower labeled lead time makes one drug universally better, that a drug half-life is the exact duration of useful erections, or that one injection system can be prepared using another system’s instructions. See ED treatment options.
A brand name may designate a specific approved product rather than every medicine containing the same active ingredient. FDA-approved generics are evaluated for the applicable reference product and dosage form; an NDC alone is not an approval certificate. Brand history and current availability also require separate checks.
We distinguish Viagra from sildenafil products intended for pulmonary arterial hypertension; Cialis ED/BPH regimens from other tadalafil indications; film-coated vardenafil from 10 mg ODT; and Caverject, Caverject Impulse and Edex rather than merging injection kits.
We place major contraindications and serious adverse-effect warning signs where readers are likely to encounter them. This includes nitrate and riociguat prohibitions for PDE5 inhibitors, vardenafil QT-related cautions, medication-metabolism interactions and the emergency significance of priapism.
We do not give unsupervised instructions to increase, split, combine or switch prescription products. A dose adjustment mentioned in a label describes prescribing context, not a recommendation for an unknown reader. See ED medication side effects.
A study should be described with its relevant population, dosage, comparator, measured endpoint and limitations. Clinical onset, Tmax, half-life and the interval during which a successful intercourse attempt was observed are different measures.
We avoid cross-trial rankings that imply direct comparative effectiveness without a suitable head-to-head study. For example, a 36-hour tadalafil ED response window must not be described as a guaranteed erection or automatically used to judge another drug’s efficacy.
EDMedix has informational pages about certain India-market product names. Such material may quote a company-listed ingredient, strength or combination, but it must distinguish documented product names from conflicting catalogs, uncertain manufacturer roles and unverified resellers.
International availability or a company advertisement does not establish FDA authorization, therapeutic equivalence, lawful U.S. importation or authentication of any shipped package. Sildenafil, tadalafil and vardenafil directories use these boundaries.
Commercial-access articles explain how to verify the actual licensed dispensing pharmacy, the clinician who makes prescribing decisions and the finished medicine supplied. A site cannot offer a lawful prescription solely by presenting a checkout page, and no article on EDMedix assures availability or prescription approval.
We do not invent pharmacy rankings, guarantee delivery deadlines or claim verified nationwide stock. FDA BeSafeRx and relevant state pharmacy boards are useful independent resources; read our online prescription and telehealth guides.
Medicine and service prices depend on product identity, authorized strength and quantity, pharmacy, billing method and insurance. We aim to explain durable cost factors rather than publish transient dollar figures, coupons or universal savings percentages.
An outside discount card may have eligibility rules or may not count toward insurance benefits. Commercial comparisons should make clear what must be confirmed directly with a pharmacy or payer. See ED medication cost factors.
EDMedix may earn compensation from eligible actions associated with links to independent third-party services. We identify sponsored or affiliate material and do not represent compensation as proof that a medicine is medically appropriate or that a provider is licensed.
A site-wide policy page is not a substitute for disclosure placed near a relevant referral or recommendation. The full Affiliate Disclosure explains the relationship and why readers should independently verify sellers.
Editorial work can verify a quoted label, source link, product identity or grammatical statement. A qualified medical review additionally evaluates whether the wording conveys appropriate clinical meaning and could mislead a patient about indications, contraindications, risk or self-treatment.
Our Medical Review Policy and reviewer standards describe what is expected. We do not attribute an individual review until a real qualified professional has performed it and consented to an accurate credit.
We welcome page-specific reports that include the inaccurate passage, a credible reference and, where applicable, the revision date. A supported correction may involve one phrase, a table, a product-status statement or a more extensive review.
Contact us through the editorial feedback page. We do not promise that every submission will lead to a particular editorial conclusion or that every article has been clinically reviewed.
We do not create fictional clinicians, report invented FDA approvals, fabricate pharmacy stock, describe unverified imported products as approved U.S. generics, promise ED treatment success or give dosing instructions based on a seller’s promotion.
We also avoid hiding commercial relationships, treating a source listing as an independent safety assessment and conflating research findings with direct patient advice.
Content on EDMedix is general educational information and cannot establish medical fitness for sexual activity or a drug-specific treatment plan. The Terms of Use describes the website’s limits.
Sudden chest pain, severe fainting, new sensory loss or a prolonged erection should not be addressed through site comments or an affiliate retailer. Seek appropriate urgent medical care.